Giardia lamblia 65 kDa antigen Antibodies

Santa Cruz Biotechnology features a diverse variety of Giardia lamblia 65 kDa antigen monoclonal antibodies for various research applications. Giardia lamblia 65 kDa antigen Antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The Giardia lamblia 65 kDa antigen plays a crucial role in the pathogenesis of giardiasis, a common intestinal infection caused by the Giardia parasite. Giardia lamblia 65 kDa antigen is involved in the organism's ability to adhere to the intestinal epithelium, making it a significant target for understanding the mechanisms of infection and developing potential therapeutic strategies. Research on Giardia lamblia 65 kDa antigen continues to advance our knowledge of parasitic diseases and improve diagnostic methods. Scientists can leverage monoclonal antibodies to investigate host-pathogen interactions and cellular mechanisms involved in giardiasis. Understanding the role of Giardia lamblia 65 kDa antigen in disease progression opens new avenues for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of parasitic infections and developing innovative treatment approaches.